Clinical trial
The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic…
NCT00327236 · Rockefeller University, Other · Completed
Key facts
| NCT number | NCT00327236 |
|---|---|
| Title | The Study of Immune Cell (T Cell) Activity in Patients With Paraneoplastic Neurologic Syndromes |
| Official title | Killer T Cell Activity in the Paraneoplastic Neurologic Syndromes |
| Lead sponsor | Rockefeller University, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Paraneoplastic Syndromes |
| Enrollment | 109 |
| Start date | Jan 1, 1995 |
| Primary completion | Feb 1, 2018 |
| Completion | Feb 1, 2018 |
| First posted | May 18, 2006 |
| Last update posted | Apr 10, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: